http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fae159c19b79fe53ddba10f91d09c1e
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Moran |
| name | Teresa Moran |
| given-name | Teresa |
| organization-name | Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Ctra Canyet s/n, 08916 Badalona, Spain ; Authors' Affiliations: 1Vanderbilt-Ingram Cancer Center, the Department of Medicine/Division of Hematology-Oncology, 2Department of Biostatistics/Division of Cancer Biostatistics, 3Center for Quantitative Science, Vanderbilt University School of Medicine; 4Departments of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee; 5Department of Pathology, 6Massachusetts General Hospital Cancer Center; 7Harvard Medical School, Boston, Massachusetts; 8Department of Pathology, 9Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 10Johns Hopkins University, Baltimore, Maryland; 11Catalan Institute of Oncology, Universitat Autonoma de Barcelona and Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; 12University of Colorado Cancer Center, Aurora, Colorado; 13Department of Surgery II, Nagoya City University Medical School, Nagoya, Japan; 14Translational Oncology Research L Medical Oncology Service, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Ctra Canyet, s/n, 08916 Badalona (Barcelona), Spain. Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Medical Oncology Department, Catalan Institute of Oncology, Hospital Germans Trias I Pujol, Universitat Autònoma de Barcelona, Applied Research Group in Oncology (B-ARGO), Badalona, Spain Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Universitat Autonoma de Barcelona, Barcelona, Spain; Massachusetts General Hospital, Boston, MA 1Catalan Institute of Oncology, Medical Oncology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain. 4Catalan Institute of Oncology, Barcelona, Spain. Catalan Institute of Oncology, Universitat Autonoma de Barcelona and Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain; 1Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain and Medical Oncology Department, Catalan Institute of Oncology Badalona, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain; Badalona Applied Research Group in Oncology (BARGO), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain Authors' Affiliations: 1Pangaea Biotech, Barcelona, Spain; 2Hospital Sant Pau, Barcelona, Spain; 3Hospital Vall d'Hebron, Barcelona, Spain; 4Molecular Oncology Research (MORe) Foundation, Barcelona, Spain; 5Pivotal, Madrid; 6Hospital General de Alicante, Alicante, Spain; 7Catalan Institute of Oncology, Badalona, Barcelona, Spain; 8Complejo Hospitalario Universitario, La Coruña, Spain; 9Centre François Baclesse, Caen, France; 10Drum Tower Hospital, Nanjing, China; 11Kyushu University, Fukuoka, Japan; 12Cancer Therapeutics Innovation Group, New York, New York, USA; and 13Helen Diller Comprehensive Cancer Center, University of California, San Francisco, California, USA Authors' Affiliations: 1Catalan Institute of Oncology, Hospital Germans Trias i Pujol; 2Hospital Germans Trias i Pujol, Badalona, Spain; 3USP Dexeus University Institute, Pangaea Biotech; 4Hospital Clinic; and 5Hospital Sant Pau, Barcelona, Spain; 6Catalan Institute of Oncology, Hospital Duran i Reynals, Bellvitge, Spain; 7Hospital Lozano Blesa, Zaragoza, Spain; 8Hospital Puerta de Hierro; 9MD Anderson; and 10Autonomous University of Madrid, Madrid, Spain; 11Hospital Carlos Haya, Malaga, Spain; 12Hospital Clinico Universitario, Valencia, Spain; 13Hospital Juan Canalejo, La Coruña, Spain; 14Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain; 15Hospital General, Alicante, Spain; 16University of Alcala de Henares, Alcala de Henares, Spain; 17Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York; and 18Howard Hughes Medical Institute, Chevy Chase, Maryland |
Incoming Links
Total number of triples: 81.